Patients with head and neck or uterine cervix cancer undergoing radiation therapy, showed decreased BChE levels before the induction of therapy, a rise during therapy and resolution to normal levels for patients remaining free of disease at 6 months follow-up [30]. The gene discussed is BCHE; the disease is cervical cancer.